For the active immunisation of healthy kittens and cats against feline leukaemia virus.
For kittens and cats in high risk environments/situations to produce a protective immunity against FeLV. Leucogen is the World's first recombinant subunit vaccine for the active immunisation of healthy kittens and cats against feline leukaemia virus.
FOR ANIMAL USE ONLY
Composition: Recombinant molecule of purified p45 feline leukaemia virus (FeLV) envelope antigen 102 μg/ml.
Warnings:
Precautions:
Directions for use: Use only as directed.
Shake well. Administer 1 ml subcutaneously or intramuscularly.
Primary vaccination: Cats 9 weeks or older: 2 doses of Leucogen 15-21 days apart. To protect kittens, it is recommended that female cats be vaccinated prior to mating.
Booster vaccination: A single dose of Leucogen is recommended annually to boost immunity. Where cats are exposed to infection, earlier revaccination may be required.
Vaccination with Leucogen can be done at the same time as other vaccinations.
Presentation: 10 single-dose vials packed in a plastic container, with package insert enclosed.
Storage instructions: Store at 2-8 °C. Protect from light. Do not freeze.
Registration numbers:
South Africa Reg. No: G2996 (Act 36/1947).
Namibia Reg. No: V06/24.2/918 NS2